Use of the Dynamic Gastric Model as a tool for investigating fed and fasted sensitivities of low polymer content hydrophilic matrix formulations.
The Dynamic Gastric Model (DGM) is an in-vitro system which aims to closely replicate the complex mixing, dynamic biochemical release and emptying patterns of the human stomach. In this study, the DGM was used to understand how the polymer content of hydrophilic matrices influences drug release in fasted and fed dissolution environments. Matrices containing a soluble model drug (caffeine) and between 10 and 30% HPMC 2208 (METHOCEL(®) K4M CR) were studied in the DGM under simulated fasted and fed conditions. The results were compared with compendial USP I and USP II dissolution tests. The USP I and II tests clearly discriminated between formulations containing different polymer levels, whereas the fasted DGM test bracketed drug release profiles into three groups and was not able to distinguish between some different formulations. DGM tests in the fed state showed that drug release was substantially influenced by the presence of a high fat meal. Under these conditions, there was a delay before initial drug release, and differences between matrices with different polymer contents were no longer clear. Matrices containing the typical amount of HPMC polymer (30% w/w) exhibited similar release rates under fed and fasted DGM conditions, but matrices with lower polymer contents exhibited more rapid drug release in the fasted state. In both the fasted and fed states erosion mechanisms appeared to dominate drug release in the DGM: most likely a consequence of the changing, cylindrical forces exerted during simulated antral cycling. This is in contrast to the USP tests in which diffusion played a significant role in the drug release process. This study is one of the first publications where a series of extended release (ER) formulations have been studied in the DGM. The technique appears to offer a useful tool to explore the potential sensitivity of ER formulations with respect to the gastric environment, especially the presence of food.
Formulation Insights, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, UK.
Laura M
LM
Mason
Model Gut Platform, Institute of Food Research, Colney, Norwich, NR4 7UA, UK.
Simona
S
Chessa
Model Gut Platform, Institute of Food Research, Colney, Norwich, NR4 7UA, UK.
Hiep
H
Huatan
Merck Sharp & Dohme Ltd., Hoddesdon, EN11 9BU, UK.
David E
DE
Storey
Pharmaceutical Sciences and Clinical Supplies, Merck and Co., Kenilworth, NJ 07033, United States.
Pranav
P
Gupta
Formulation Insights, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, UK.
Jonathan
J
Burley
Formulation Insights, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, UK. Electronic address: colin.melia@nottingham.ac.uk.
Colin D
CD
Melia
D002626:Chemistry, Pharmaceutical; D004041:Dietary Fats / Q000008:administration & dosage; D005215:Fasting; D005746:Gastric Emptying; D057927:Hydrophobic and Hydrophilic Interactions; D008954:Models, Biological; D011108:Polymers / Q000032:analysis / Q000737:chemistry*
D004041:Dietary Fats; D011108:Polymers
Biorelevant dissolution; Dynamic Gastric Model; Food effect; Hydrophilic matrix; Hydroxypropyl methylcellulose; Oral drug delivery